FDA Orange Book
Is there a generic for AdreView?
AdreView contains iobenguane sulfate i-123. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for AdreView (iobenguane sulfate i-123).
Run it in Rivvi
Map AdreView and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
AdreView products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intravenous | 10mCi/5ML (2mCi/ML) | Marketed (Rx) | None | 0 | None |
NDA 022290, held by GE HEALTHCARE. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
AdreView NDC codes
Questions
Is there a generic for AdreView?
No. The Orange Book lists no active FDA-approved generic (ANDA) for AdreView (iobenguane sulfate i-123).
What is the generic name for AdreView?
The active ingredient in AdreView is iobenguane sulfate i-123, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.